Hubei Yuancheng Baofeng Technology Co.

Hubei Yuancheng Baofeng Technology Co.

You are here: HomeProductsYohimbine HCl (Extract) CAS NO: 65-19-0 roy@yccreate.com

Contact us

  • Company Name: Hubei Yuancheng Baofeng Technology Co.
  • Country/region: China
  • Contact Person: Ms.Roy Ye
  • Tel: 86-027-50756025
  • Email:

Yohimbine HCl (Extract) CAS NO: 65-19-0 roy@yccreate.com

  • Product NameYohimbine HCl (Extract) CAS NO: 65-19-0 roy@yccreate.com
    CAS No.65-19-0
    Purity99%
    Min QuantityKilograms
    Price1~10
  • View Contact Detail
  • CAS No:65-19-0 Yohimbine hydrochloride
    Molecular Structure

    Detailed Description

    Yohimbine HCl (Extract)

    CAS NO: 65-19-0 L 8%,98% by HPLC

    Plant original: Pausinystalia Yohimbe

    Specifications: 8~98% Yohimbine HCL by HPLC

    Molecular Formula: C21H27ClN2O

    Molecular Weight: 390.904

    CAS NO: 65-19-0

    Indications and Uses

    Yohimbine hydrochloride is indicated as a sympathicolytic and mydriatic. It may have activity as an aphrodisiac.

    Impotence (not able to have erections)

    The way yohimbine works is not known for sure. It is thought, however, to work by increasing the body's production of certain chemicals that help produce erections. It does not work in all men who are impotent.

    New research that shows it could be an herb with very effective antioxidant potential. Research shows it is a vasodilator, which means that it increases blood flow to the extremities and appendages.

    Safety Concerns

    Patients sensitive to rauwolfia alkaloids such as deserpidine, rauwolfia serpentina, or reserpine may also be sensitive to yohimbine.

    Yohimbine readily penetrates the (CNS) and produces a complex pattern of responses in lower doses than those required to produce peripheral alpha-adrenergic blockade. These include, anti-diuresis, a general picture of central excitation including elevation of blood pressure and heart rate, increased motor activity, nervousness, irritability and tremor. Sweating, nausea and vomiting are common after parenteral administration of the drug. Also, dizziness, headache skin flushing reported when used orally.

    Generally, this drug is not proposed for use in females and certainly must not be used during pregnancy. Neither is this drug proposed for use in pediatric, geriatric or cardio-renal patients with gastric or duodenal ulcer history. Nor should it be used in conjunction with mood- modifying drugs such as antidepressants, or in psychiatric patients in general.

    Renal diseases and patient's sensitive to the drug. In view of the limited and inadequate information at hand, no precise tabulation can be offered of additional contraindications.
  • Yohimbine HCl (Extract)  CAS NO: 65-19-0 roy@yccreate.com
  • Yohimbine HCl (Extract) CAS NO: 65-19-0 roy@yccreate.com